
Monozyme India Limited
Manufactures and trades medical instruments and kits for biochemistry, serology, immunology, and microbiology tests.
Manufactures and trades medical instruments and kits for biochemistry, serology, immunology, and microbiology tests.
Monozyme India Limited (MIL) is a Public Limited Indian Non-Government Company incorporated in India on 07 July 1989 and has a history of 35 years and nine months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Monozyme India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.12 Cr.
The company currently has active open charges totaling ₹7.59 Cr. The company has closed loans amounting to ₹12.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anand Maloo, Rabindra Walia, Bijinder Rattan, and Two other members serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
L24239TG1989PLC010220
010220
Public Limited Indian Non-Government Company
07 Jul 1989
30 Sep 2023
31 Mar 2023
Listed
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anand Maloo ![]() | Director | 30-Oct-2004 | Current |
Rabindra Walia ![]() | Director | 16-Feb-2008 | Current |
Bijinder Rattan ![]() | Director | 01-Feb-2007 | Current |
Kali Sharma ![]() | Director | 16-Feb-2008 | Current |
Veeram Reddy ![]() | Director | 28-Feb-2005 | Current |
Monozyme India Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.5% decrease. The company also saw a slight improvement in profitability, with a 5.15% increase in profit. The company's net worth dipped by a decrease of 0.55%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Monozyme India had a public holding of 100.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Anand Maloo is a mutual person
Rabindra Walia is a mutual person
Rabindra Walia is a mutual person
Rabindra Walia is a mutual person
Rabindra Walia is a mutual person
Kali Sharma is a mutual person
₹7.59 Cr
₹12.21 Cr
Date | Lender | Amount | Status |
---|---|---|---|
10 Sep 2005 | Oriental Bank Commarce | ₹7.15 Cr | Open |
29 Mar 1990 | Technology Developmen And Inforanationcompanyof India Limite | ₹4.40 M | Open |
07 Mar 2001 | State Bank Of Hyderabad | ₹2.00 Cr | Satisfied |
07 Mar 2001 | State Bank Of Hyderabad | ₹2.00 Cr | Satisfied |
03 Jun 1996 | State Bank Of Hyderabad | ₹8.10 M | Satisfied |
Unlock and access historical data on people associated with Monozyme India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Monozyme India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Monozyme India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Monozyme India Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Monozyme India Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
A charge registered on 07 Mar 2001 via Charge ID 90124233 with State Bank Of Hyderabad was fully satisfied on 30 Mar 2010.
A charge registered on 07 Mar 2001 via Charge ID 90122952 with State Bank Of Hyderabad was fully satisfied on 30 Mar 2010.
A charge registered on 03 Jun 1996 via Charge ID 90123860 with State Bank Of Hyderabad was fully satisfied on 30 Mar 2010.
A charge registered on 23 Feb 1996 via Charge ID 90123848 with State Bank Of Hyderabad was fully satisfied on 30 Mar 2010.
Monozyme India Limited was incorporated on 07 Jul 1989.
The authorized share capital of Monozyme India Limited is ₹ 4.00 Cr and paid-up capital is ₹ 3.12 Cr.
Currently 5 directors are associated with Monozyme India Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Monozyme India Limited is First Floor H.No.1-5-1002/3 Sri Sai Krupa Nagar Colony Bhoopathi Rao Nagar, O Alwal India, Secunderabad, Telangana, 500010.
The corporate identification number (CIN) of Monozyme India Limited is L24239TG1989PLC010220 and the company number is 010220 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Monozyme India Limited has fallen by -37.50%.
The financial reports for the fiscal year 2023 indicates that The net worth of Monozyme India Limited has experienced an downturn of -0.55%.
As per the financial statements for fiscal Year 2023, The total open charges for Monozyme India Limited amount to ₹ 7.59 Cr.
The most recent Balance Sheet for Monozyme India Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
AS